T1	SNP 13 26	polymorphisms
T2	Entity 0 7	HSD17B1
T3	Association 31 35	risk
E1	Association:T3 snp_int:T1 bc:T4
T4	Cancer 55 68	breast cancer
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T5	Spec 230 242	hypothesized
T6	SNP 248 266	genetic variations
T7	Entity 270 277	HSD17B1
R2	SNP_coupled_gene Arg1:T6 Arg2:T7	
T8	Organic_inorganic_molecules_affected 287 292;313 319	alter levels
E2	Organic_inorganic_molecules_affected:T8 Theme:T9 Agent:T6
T9	Entity 293 312	endogenous estrogen
T10	Association 331 340	influence
E3	Association:T10 snp_int:T6 bc:T11
T11	Cancer 357 370	breast cancer
R3	Speculation_marker Arg1:E3 Arg2:T5	
T12	Spec 442 450	assessed
T14	SNP 498 502	SNPs
T15	SNP 465 496	single nucleotide polymorphisms
R4	Equiv Arg1:T14 Arg2:T15	
T16	SNP 404 417	polymorphisms
T17	Entity 425 432	HSD17B1
R5	SNP_coupled_gene Arg1:T16 Arg2:T17	
T13	Interaction 520 530	haplotypes
E4	Interaction:T13 
T18	Association 537 547	associated
E5	Association:T18 snp_int:E4 snp_int2:T16 bc:T19
T19	Cancer 569 582	breast cancer
R6	SNP_coupled_gene Arg1:E4 Arg2:T17	
R7	Speculation_marker Arg1:E5 Arg2:T12	
T20	Spec 597 605	assessed
T21	Entity 616 635	priori risk factors
T22	Association 649 661	associations
E6	Association:T22 bc:T24 snp_int:T25
R8	Speculation_marker Arg1:E6 Arg2:T20	
T23	Entity 670 677	HSD17B1
T24	Cancer 691 697	cancer
T25	SNP 404 417	polymorphisms
R9	SNP_coupled_gene Arg1:T25 Arg2:T23	
R10	Risk_Factor Arg1:T25 Arg2:T21	
T26	Spec 708 715	whether
T27	Organic_inorganic_molecules_affected 755 761;771 777	plasma levels
E7	Organic_inorganic_molecules_affected:T27 Theme:T28 Agent:T25
T28	Entity 762 770	estrogen
R11	Speculation_marker Arg1:E7 Arg2:T26	
T29	Entity 799 804	women
R12	Population_assignment Arg1:T25 Arg2:T29	
T30	Entity 784 798	postmenopausal
T31	Neg 805 808	not
T32	Entity 815 842	hormone replacement therapy
R13	Negation_marker Arg1:T32 Arg2:T31	
R14	Member Arg1:T21 Arg2:T30	
R15	Member Arg1:T21 Arg2:T32	
T33	Entity 890 895	women
R16	Population_assignment Arg1:T16 Arg2:T33	
R17	Population_assignment Arg1:T6 Arg2:T33	
T34	SNP 844 852	Ten SNPs
R18	Equiv Arg1:T34 Arg2:T16	
R19	Equiv Arg1:T34 Arg2:T6	
T35	SNP 1177 1185	+1004C/T
A1	SNP_Class T35 tSNP
T36	SNP 1190 1198	+1322C/A
A2	SNP_Class T36 tSNP
T37	SNP 1234 1242	+1954A/G
R20	Population_assignment Arg1:T35 Arg2:T33	
R21	Population_assignment Arg1:T36 Arg2:T33	
R22	Population_assignment Arg1:T37 Arg2:T33	
T38	Entity 856 863	HSD17B1
R23	SNP_coupled_gene Arg1:T35 Arg2:T38	
R24	SNP_coupled_gene Arg1:T36 Arg2:T38	
R25	SNP_coupled_gene Arg1:T37 Arg2:T38	
T39	Entity 1177 1182	+1004
R26	SNP_location Arg1:T35 Arg2:T39	
T40	Entity 1190 1195	+1322
R27	SNP_location Arg1:T36 Arg2:T40	
T41	Entity 1182 1185	C/T
T42	Entity 1195 1198	C/A
T43	Entity 1234 1239	+1954
T44	Entity 1239 1242	A/G
T45	SNP 1244 1253	Ser312Gly
R28	Nucleotide_substitution Arg1:T35 Arg2:T41	
R29	Nucleotide_substitution Arg1:T36 Arg2:T42	
R30	SNP_location Arg1:T37 Arg2:T43	
R31	Nucleotide_substitution Arg1:T37 Arg2:T44	
A3	SNP_Type T35 Missense
T46	Neg 1439 1441	no
T47	Association 1450 1461	association
E8	Association:T47 snp_int:T35 snp_int2:T36 snp_int3:T37 bc:T48
R32	Negation_marker Arg1:E8 Arg2:T46	
T48	Cancer 1524 1537	breast cancer
T49	SNP 1548 1556	+1954A/A
T50	Entity 1548 1553	+1954
T51	Entity 1553 1556	A/A
R33	Genotype Arg1:T49 Arg2:T51	
R34	SNP_location Arg1:T49 Arg2:T50	
R35	SNP_coupled_gene Arg1:T49 Arg2:T38	
T52	Effect_Type 1586 1592	higher
T54	Organic_inorganic_molecules_affected 1603 1609	levels
E10	Organic_inorganic_molecules_affected:T54 Agent:T49 Theme:T53
T53	Entity 1593 1602	estradiol
R36	Effect_type_marker Arg1:E10 Arg2:T52	
A4	Effect_Type E10 Increase
T55	Entity 1613 1617	lean
R37	Risk_Factor Arg1:T49 Arg2:T55	
T56	Entity 1618 1623	women
R38	Population_assignment Arg1:T49 Arg2:T56	
T57	Association 1639 1650	interaction
E9	Association:T57 bc:T63
T58	Spec 1746 1755	suggested
R39	Speculation_marker Arg1:E9 Arg2:T58	
T59	Entity 1702 1716	postmenopausal
T60	SNP 1663 1668	+1954
T61	Entity 1683 1698	body mass index
R40	Risk_Factor Arg1:T60 Arg2:T61	
R41	Risk_Factor Arg1:T60 Arg2:T59	
R42	SNP_coupled_gene Arg1:T60 Arg2:T38	
T62	Entity 1663 1668	+1954
R43	SNP_location Arg1:T60 Arg2:T62	
R44	Population_assignment Arg1:T60 Arg2:T56	
R45	Genotype Arg1:T60 Arg2:T51	
T63	Cancer 1717 1730	breast cancer
R46	Equiv Arg1:T37 Arg2:T45	
T64	Organic_inorganic_molecules_affected 1244 1253	Ser312Gly
E11	Organic_inorganic_molecules_affected:T64 Agent:T45 Theme:T65
T65	Entity 1244 1250	Ser312
A5	SNP_Type T37 Missense
